Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division
© 2020 National Academy of Sciences. All rights reserved. Aneuploidy, defined as whole chromosome gains and losses, is associated with poor patient prognosis in many cancer types. However, the condition causes cellular stress and cell cycle delays, foremost in G1 and S phase. Here, we investigate ho...
Main Authors: | Replogle, John Michael, Zhou, Wen, Amaro, Adrianna E, McFarland, James M, Villalobos-Ortiz, Mariana, Ryan, Jeremy, Letai, Anthony, Yilmaz, Omer, Sheltzer, Jason, Lippard, Stephen J, Ben-David, Uri, Amon, Angelika |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Proceedings of the National Academy of Sciences
2021
|
Online Access: | https://hdl.handle.net/1721.1/133334 |
Similar Items
-
The aneuploidy paradox: costs and benefits of an incorrect karyotype
by: Sheltzer, Jason Meyer, et al.
Published: (2018) -
Transcriptional consequences of aneuploidy
by: Sheltzer, Jason Meyer, et al.
Published: (2013) -
Context is everything: aneuploidy in cancer
by: Ben-David, Uri, et al.
Published: (2020) -
The pleiotropic deubiquitinase Ubp3 confers aneuploidy tolerance
by: Sheltzer, Jason, et al.
Published: (2018) -
Mitotic entry in the presence of DNA damage is a widespread property of aneuploidy in yeast
by: Sheltzer, Jason Meyer, et al.
Published: (2015)